# Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/chimeric-antigen-receptor-4scar-gd2-modified-t-cells-targeting-high-risk-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lihua Yang,Xiaoli Ma,Yuchen Liu,Wen Zhao,Lihua Yu,Maoquan Qin,Guanghua Zhu,Kai Wang,Xiaodong Shi,Zhaoxia Zhang,Jingfu Wang,Yuan Sun,Lujia Dong,Shih-Ting Tsao,Rui Zhang,Lung‐Ji Chang |
| Citations | 24 |
| DOI | 10.1182/blood.v130.suppl_1.3335.3335 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2990192944 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Maoquan Qin](https://scholariq.org/researchers/maoquan-qin/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)

## Paper topics

- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.